Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically

NCT02808975 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)

Interventions

DRUG: Placebo
DRUG: Adalimumab

Sponsor

AbbVie